BrainsWay (BWAY) submits Form 6-K with Q3 2025 results release

Rhea-AI Filing Summary

BrainsWay Ltd., an Israel-based foreign private issuer, submitted a Form 6-K for November 2025. The report furnishes Exhibit 99.1, a press release titled “BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights.” The filing is incorporated by reference into the company’s existing Form S-8 and two Form F-3 registration statements and is signed by Chief Executive Officer Hadar Levy.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number: 001-35165

BRAINSWAY LTD.
(Translation of registrant's name into English)

16 Hartum Street RAD Tower, 14th Floor
Har HaHotzvim
Jerusalem, 9777516, Israel
(+972-2) 582-4030
 (Address and telephone number of Registrant’s principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ]      Form 40-F [   ]

This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on April 22, 2019 (Registration No. 333- 230979) and the Company's Registration Statements on Form F-3 filed with the Securities and Exchange Commission on July 22, 2024 (Registration No. 333-280934) and on April 22, 2025 (Registration No. 333-286672).

EXHIBIT INDEX

Exhibit		Title
99.1		BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		BRAINSWAY LTD.
		(Registrant)
Date: November 12, 2025		/s/ Hadar Levy
		Hadar Levy
		Chief Executive Officer

FAQ

What did BrainsWay (BWAY) file in this Form 6-K?

BrainsWay filed a Form 6-K as a foreign private issuer, furnishing Exhibit 99.1 titled “BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights.” The report updates U.S. investors with this information under the Securities Exchange Act of 1934.

What is included as Exhibit 99.1 in BrainsWay’s Form 6-K?

Exhibit 99.1 is a press release titled “BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights.” It contains the company’s Q3 2025 financial information and operational updates, which are being formally furnished to the SEC through this submission.

How does this BrainsWay (BWAY) Form 6-K interact with its registration statements?

The Form 6-K is incorporated by reference into BrainsWay’s Form S-8 filed April 22, 2019 and its Form F-3 registration statements filed July 22, 2024 and April 22, 2025. This allows the Q3 2025 information to be part of those offering documents.

Which SEC annual report form does BrainsWay use as a foreign issuer?

BrainsWay indicates it files its annual reports on Form 20-F rather than Form 40-F. This confirms it follows the Form 20-F disclosure framework used by many foreign private issuers listing securities in the United States.

Who signed the BrainsWay (BWAY) November 2025 Form 6-K?

The Form 6-K was signed on behalf of BrainsWay Ltd. by Chief Executive Officer Hadar Levy, dated November 12, 2025. This signature confirms the company’s authorization of the furnished Q3 2025 results and related information.